Successful treatment of refractory red cell aplasia after allogeneic hematopoietic cell transplantation with daratumumab-Reference-Cited by-同舟云学术

Successful treatment of refractory red cell aplasia after allogeneic hematopoietic cell transplantation with daratumumab

Published:2019-11-20 Issue:2 Volume:104 Page:145-147
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Salas Maria Queralt¹²^ORCID,Alahmari Ali¹²,Lipton Jeffrey Howard¹²

Affiliation:

1. Section of Medical Oncology and Hematology Department of Medicine University of Toronto Toronto ON Canada

2. Hans Messner Allogeneic Blood and Marrow Transplantation Program Division of Medical Oncology and Hematology Princess Margaret Cancer Centre University Health Network Toronto ON Canada

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13343

Reference5 articles.

1. Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation

2. Successful treatment of pure red cell aplasia because of ABO major mismatched stem cell transplant

3. Subcutaneous bortezomib is highly effective for pure red cell aplasia after ABO-incompatible haematopoietic stem cell transplantation

4. Daratumumab for Delayed Red-Cell Engraftment after Allogeneic Transplantation

5. Refractory postallogeneic stem cell transplant pure red cell aplasia in remission after treatment with daratumumab

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aplastic anemia in association with multiple myeloma: clinical and pathophysiological insights;Leukemia & Lymphoma;2024-09-03

2. Seven-years post allogeneic hematopoietic stem cell transplantation pure red cell aplastic anemia cured with daratumumab: A case report and review of literature;World Journal of Clinical Cases;2024-08-26

3. Pure red cell aplasia among ABO mismatched hematopoietic stem cell transplant recipients: a 13-years retrospective study and literature review;Frontiers in Oncology;2024-07-02

4. Gilteritinib combined with venetoclax and azacitidine for relapsed acute myeloid leukemia cocurrent with pure red cell aplasia after allogeneic hematopoietic stem cell transplantation: a case report;Annals of Hematology;2024-04-01

5. Efficacy and safety of Daratumumab for the treatment of ABO-incompatible pure red cell aplasia after allogenic HSCT: report from SFGM-TC;Bone Marrow Transplantation;2024-03-09